Table of Content

1. Executive Summary


2. Introduction

2.1 Cardiogenic Shock: An Overview
2.1.1 Introduction to Cardiogenic Shock
2.1.2 Ways to Reduce Cardiogenic Shock Risk

2.2 Cardiogenic Shock Segmentation: An Overview
2.2.1 Cardiogenic Shock Segmentation


3. Global Market Analysis

3.1 Global Cardiogenic Shock Market: An Analysis

3.1.1 Global Cardiogenic Shock Market: An Overview
3.1.2 Global Cardiogenic Shock Market by Value
3.1.3 Global Cardiogenic Shock Market by Treatment Type
3.1.4 Global Cardiogenic Shock Market by End-user
3.1.5 Global Cardiogenic Shock Market by Region

3.2 Global Cardiogenic Shock Market: Treatment Type Analysis

3.2.1 Global Cardiogenic Shock Market by Treatment Type: An Overview
3.2.2 Global Drugs Cardiogenic Shock Market by Value
3.2.3 Global Mechanical Circulatory Support (MCS) Devices Cardiogenic Shock Market by Value
3.2.4 Global Other Cardiogenic Shock Market by Value

3.3 Global Cardiogenic Shock Market: End-user Analysis

3.3.1 Global Cardiogenic Shock Market by End-user: An Overview
3.3.2 Global Hospitals & Clinics Cardiogenic Shock Market by Value
3.3.3 Global Specialty Cardiac Centers Cardiogenic Shock Market by Value
3.3.4 Global Ambulatory Surgical Centers Cardiogenic Shock Market by Value
3.3.5 Global Others Cardiogenic Shock Market by Value


4. Regional Market Analysis

4.1 North America Cardiogenic Shock Market: An Analysis

4.1.1 North America Cardiogenic Shock Market: An Overview
4.1.2 North America Cardiogenic Shock Market by Value
4.1.3 North America Cardiogenic Shock Market by Region
4.1.4 The US Cardiogenic Shock Market by Value
4.1.5 Canada Cardiogenic Shock Market by Value
4.1.6 Mexico Cardiogenic Shock Market by Value

4.2 Europe Cardiogenic Shock Market: An Analysis

4.2.1 Europe Cardiogenic Shock Market: An Overview
4.2.2 Europe Cardiogenic Shock Market by Value
4.2.3 Europe Cardiogenic Shock Market by Region
4.2.4 Germany Cardiogenic Shock Market by Value
4.2.5 United Kingdom Cardiogenic Shock Market by Value
4.2.6 France Cardiogenic Shock Market by Value
4.2.7 Italy Cardiogenic Shock Market by Value
4.2.8 Spain Cardiogenic Shock Market by Value
4.2.9 Rest of Europe Cardiogenic Shock Market by Value

4.3 Asia Pacific Cardiogenic Shock Market: An Analysis

4.3.1 Asia Pacific Cardiogenic Shock Market: An Overview
4.3.2 Asia Pacific Cardiogenic Shock Market by Value
4.3.3 Asia Pacific Cardiogenic Shock Market by Region
4.3.4 China Cardiogenic Shock Market by Value
4.3.5 Japan Cardiogenic Shock Market by Value
4.3.6 India Cardiogenic Shock Market by Value
4.3.7 South Korea Cardiogenic Shock Market by Value
4.3.8 Rest of Asia Pacific Cardiogenic Shock Market by Value

4.4 Latin America Cardiogenic Shock Market: An Analysis

4.4.1 Latin America Cardiogenic Shock Market: An Overview
4.4.2 Latin America Cardiogenic Shock Market by Value

4.5 Middle East & Africa Cardiogenic Shock Market: An Analysis

4.5.1 Middle East & Africa Cardiogenic Shock Market: An Overview
4.5.2 Middle East & Africa Cardiogenic Shock Market by Value


5. Impact of COVID-19

5.1 Impact of COVID-19 on Global Cardiogenic Shock Market
5.2 Post COVID-19 Impact on Global Cardiogenic Shock Market


6. Market Dynamics

6.1 Growth Drivers
6.1.1 Increase in the Global Geriatric Population
6.1.2 Increasing Incidence of Heart Disease
6.1.3 Growing Healthcare Expenditure
6.1.4 Growing Prevalence of Sedentary Lifestyle
6.1.5 Rising Awareness and Early Diagnosis

6.2 Challenges
6.2.1 High Cost of Advanced Therapies and Devices
6.2.2 Shortage of Skilled Healthcare Professionals

6.3 Market Trends
6.3.1 Rise in Adoption of Artificial Intelligence
6.3.2 Technological Advancements in Mechanical Circulatory Support (MCS) Devices
6.3.3 Development of Novel Pharmacological Therapies
6.3.4 Rise in Research and Development Activities
6.3.5 Adoption of Minimally Invasive Techniques
6.3.6 Rising Demand for Point-of-Care (POC) Testing


7. Competitive Landscape

7.1 Global Cardiogenic Shock Market Players: Recent Developments


8. Company Profiles

8.1 Abbott
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy

8.2 Medtronic plc
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy

8.3 Boston Scientific Corporation
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy

8.4 AstraZeneca Plc
8.4.1 Business Overview
8.4.2 Business Strategies

8.5 Roche Holdings AG
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy

8.6 Bayer AG
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy

8.7 Getinge
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy

8.8 Johnson & Johnson (Abiomed)
8.8.1 Business Overview
8.8.2 Business Segments
8.8.3 Business Strategy

8.9 Viatris, Inc.
8.9.1 Business Overview
8.9.2 Operating Segments
8.9.3 Business Strategy

8.10 Terumo Corporation
8.10.1 Business Overview
8.10.2 Operating Segments
8.10.3 Business Strategy

8.11 Endo International plc (Par Pharmaceutical)
8.11.1 Business Overview
8.11.2 Operating Segments
8.11.3 Business Strategy

8.12 Windtree Therapeutics, Inc.
8.12.1 Business Overview
8.12.2 Business Strategy
8.13 ZOLL Medical Corporation

8.13.1 Business Overview
8.13.2 Business Strategy

List of Figures

Figure 1: Ways to Reduce Cardiogenic Shock Risk
Figure 2: Cardiogenic Shock Segmentation
Figure 3: Global Cardiogenic Shock Market by Value; 2020-2024 (US$ Billion)
Figure 4: Global Cardiogenic Shock Market by Value; 2025-2030 (US$ Billion)
Figure 5: Global Cardiogenic Shock Market by Treatment Type; 2024 (Percentage, %)
Figure 6: Global Cardiogenic Shock Market by End-user; 2024 (Percentage, %)
Figure 7: Global Cardiogenic Shock Market by Region; 2024 (Percentage, %)
Figure 8: Global Drugs Cardiogenic Shock Market by Value; 2020-2024 (US$ Billion)
Figure 9: Global Drugs Cardiogenic Shock Market by Value; 2025-2030 (US$ Billion)
Figure 10: Global Mechanical Circulatory Support (MCS) Devices Cardiogenic Shock Market by Value; 2020-2024 (US$ Billion)
Figure 11: Global Mechanical Circulatory Support (MCS) Devices Cardiogenic Shock Market by Value; 2025-2030 (US$ Billion)
Figure 12: Global Other Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 13: Global Other Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 14: Global Hospitals & Clinics Cardiogenic Shock Market by Value; 2020-2024 (US$ Billion)
Figure 15: Global Hospitals & Clinics Cardiogenic Shock Market by Value; 2025-2030 (US$ Billion)
Figure 16: Global Specialty Cardiac Centers Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 17: Global Specialty Cardiac Centers Cardiogenic Shock Market by Value; 2025-2030 (US$ Billion)
Figure 18: Global Ambulatory Surgical Centers Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 19: Global Ambulatory Surgical Centers Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 20: Global Others Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 21: Global Others Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 22: North America Cardiogenic Shock Market by Value; 2020-2024 (US$ Billion)
Figure 23: North America Cardiogenic Shock Market by Value; 2025-2030 (US$ Billion)
Figure 24: North America Cardiogenic Shock Market by Region; 2024 (Percentage, %)
Figure 25: The US Cardiogenic Shock Market by Value; 2020-2024 (US$ Billion)
Figure 26: The US Cardiogenic Shock Market by Value; 2025-2030 (US$ Billion)
Figure 27: Canada Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 28: Canada Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 29: Mexico Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 30: Mexico Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 31: Europe Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 32: Europe Cardiogenic Shock Market by Value; 2025-2030 (US$ Billion)
Figure 33: Europe Cardiogenic Shock Market by Region; 2024 (Percentage, %)
Figure 34: Germany Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 35: Germany Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 36: United Kingdom Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 37: United Kingdom Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 38: France Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 39: France Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 40: Italy Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 41: Italy Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 42: Spain Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 43: Spain Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 44: Rest of Europe Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 45: Rest of Europe Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 46: Asia Pacific Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 47: Asia Pacific Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 48: Asia Pacific Cardiogenic Shock Market by Region; 2024 (Percentage, %)
Figure 49: China Cardiogenic Shock Market by Value, 2020-2024 (US$ Million)
Figure 50: China Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 51: Japan Cardiogenic Shock Market by Value, 2020-2024 (US$ Million)
Figure 52: Japan Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 53: India Cardiogenic Shock Market by Value, 2020-2024 (US$ Million)
Figure 54: India Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 55: South Korea Cardiogenic Shock Market by Value, 2020-2024 (US$ Million)
Figure 56: South Korea Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 57: Rest of Asia Pacific Cardiogenic Shock Market by Value, 2020-2024 (US$ Million)
Figure 58: Rest of Asia Pacific Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 59: Latin America Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 60: Latin America Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 61: Middle East & Africa Cardiogenic Shock Market by Value; 2020-2024 (US$ Million)
Figure 62: Middle East & Africa Cardiogenic Shock Market by Value; 2025-2030 (US$ Million)
Figure 63: Global Percentage Of Population Aged 65 Years Or Over; 2022, 2030 & 2050 (Percentage, %)
Figure 64: Global Trends in Number of Deaths Due to Cardiovascular Diseases; 2019 and 2021 (Million)
Figure 65: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2022 (Percentage, %)
Figure 66: Global Prevalence of Insufficient Physical Activity Among Adults; 2010, 2022 and 2030 (Percentage, %)
Figure 67: Global Artificial Intelligence (AI) in Healthcare Market; 2021-2030 (US$ Billion)
Figure 68: Abbott Sales by Segments; 2023 (Percentage, %)
Figure 69: Medtronic plc Net Sales by Segment: 2023 (Percentage, %)
Figure 70: Boston Scientific Corp. Net Sales by Segment: 2023 (Percentage, %)
Figure 71: Roche Holdings AG Sales by Operating Segment; 2024 (Percentage, %)
Figure 72: Bayer AG Net Sales by Segment; 2023 (Percentage, %)
Figure 73: Getinge Sales by Segment: 2023 (Percentage, %)
Figure 74: Johnson & Johnson Sales by Business Segment; 2023 (Percentage, %)
Figure 75: Viatris, Inc. Sales by Segment: 2023 (Percentage, %)
Figure 76: Terumo Corporation Revenue by Company: 2023 (Percentage, %)
Figure 77: Endo International plc Revenue by Company: 2023 (Percentage, %)